RxDoctor Payments Data

Francesco Santoni-Rugiu, MD

Clinical Cardiac Electrophysiology · New York, NYNPI 1821024696

Payments from drug & device makers

$8,279in general payments, 2019–2025

Across 153 payments — averaging $54.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$6K
  • Biosense Webster, Inc.$793
  • Medtronic$753
  • Abbott$329
  • Biotronik Inc.$148
  • Novo Nordisk$124
  • plus $463 from 8 others

What the payments were for

  • Travel & lodging$1,37217%
  • Food & beverage$6,90783%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,279 in reported general payments places this provider in the 25th percentile of 214 clinical cardiac electrophysiology providers in New York.

See all clinical cardiac electrophysiology providers in New York

Medicare billing

Part B allowed, 2024
$69,528
Medicare patients
374
Services billed
842

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban185$207,211
XareltoRivaroxaban27$27,918
MultaqDronedarone Hcl18$20,511
Dofetilide38$9,431
Flecainide Acetate22$1,708
Metoprolol Succinate81$1,475
Amiodarone Hcl29$944
Diltiazem 24hr Er (Cd)Diltiazem Hcl17$591
SotalolSotalol Hcl14$357
Metoprolol Tartrate26$109

Paid to pharmacies, not to this prescriber.

Other clinical cardiac electrophysiology in New York

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →